Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly (Q37078949)

18 August 2017

1 reference

title

Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly (English)

1 reference

18 August 2017

1 reference

Bodh I Jugdutt

1

1 reference

18 August 2017

7 February 2008

1 reference

18 August 2017

Heart Failure Reviews

1 reference

18 August 2017

13

1 reference

18 August 2017

4

1 reference

18 August 2017

439-452

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-008-9090-1

18 August 2017

0 references

cites work

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Aldosterone induces a vascular inflammatory phenotype in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Reduction of myocardial infarct size by fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Collagen degradation in ischaemic rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Effect of indomethacin on collateral blood flow and infarct size in the conscious dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9090-1

Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts

21 January 2018

1 reference

12 December 2020

Early angiography after myocardial infarction: What have we learned?

1 reference

12 December 2020

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial

1 reference

12 December 2020

Impact of increased infarct transmurality on remodeling and function during healing after anterior myocardial infarction in the dog

1 reference

12 December 2020

Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction

1 reference

12 December 2020

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

12 December 2020

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

1 reference

12 December 2020

Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group

1 reference

12 December 2020

Limitation of left ventricular hypertrophy and dysfunction by ACE inhibition after anterior Q-wave myocardial infarction

1 reference

12 December 2020

Endothelin receptors in cultured adult rat cardiac fibroblasts

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog

1 reference

12 December 2020

Collagen loss in the stunned myocardium

1 reference

12 December 2020

Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy

1 reference

12 December 2020

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

12 December 2020

Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model

1 reference

12 December 2020

GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico

1 reference

12 December 2020

Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat

1 reference

12 December 2020

Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group

1 reference

12 December 2020

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

1 reference

12 December 2020

Effects of reperfusion after coronary artery occlusion on post-infarction scar tissue

1 reference

12 December 2020

Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.

1 reference

12 December 2020

Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium.

1 reference

12 December 2020

Cardioprotection induced by AT1R blockade after reperfused myocardial infarction: association with regional increase in AT2R, IP3R and PKCepsilon proteins and cGMP

1 reference

12 December 2020

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

1 reference

12 December 2020

Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction†

1 reference

12 December 2020

Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography

1 reference

12 December 2020

Losartan increases bradykinin levels in hypertensive humans

1 reference

12 December 2020

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

1 reference

12 December 2020

1 reference

12 December 2020

Coronary arteriographic findings soon after non-Q-wave myocardial infarction

1 reference

12 December 2020

The histopathologic evolution of myocardial infarction

1 reference

12 December 2020

Transmural cellular damage and blood flow distribution in early ischemia in pig hearts

1 reference

12 December 2020

Subacute and chronic effects of quinapril on cardiac cytokine expression, remodeling, and function after myocardial infarction in the rat.

1 reference

12 December 2020

Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Ger

1 reference

12 December 2020

Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat: importance of timing

1 reference

12 December 2020

Angiotensin I converting enzyme inhibitors and cardiac remodeling

1 reference

12 December 2020

Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models

1 reference

12 December 2020

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

12 December 2020

Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart

1 reference

12 December 2020

Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction

1 reference

12 December 2020

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

12 December 2020

Therapeutic drugs during healing after myocardial infarction modify infarct collagens and ventricular distensibility at elevated pressures.

1 reference

12 December 2020

Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Mio

1 reference

12 December 2020

Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion

1 reference

12 December 2020

Functional impact of remodeling during healing after non-Q wave versus Q wave anterior myocardial infarction in the dog

1 reference

12 December 2020

Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways

1 reference

12 December 2020

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

12 December 2020

Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications

1 reference

12 December 2020

Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional ("stunned") but viable myocardium.

1 reference

12 December 2020

Effects of endothelins on collagen turnover in cardiac fibroblasts

1 reference

12 December 2020

Myocardial infarct expansion during indomethacin or ibuprofen therapy for symptomatic post infarction pericarditis. Influence of other pharmacologic agents during early remodelling.

1 reference

12 December 2020

Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.

1 reference

12 December 2020

Healing after myocardial infarction

1 reference

12 December 2020

Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion

1 reference

12 December 2020

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

12 December 2020

Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group.

1 reference

12 December 2020

Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockade

1 reference

12 December 2020

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

1 reference

12 December 2020

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collabor

1 reference

12 December 2020

Enhanced regional AT(2)-receptor and PKC(epsilon) expression during cardioprotection induced by AT(1)-receptor blockade after reperfused myocardial infarction

1 reference

12 December 2020

Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation

1 reference

12 December 2020

Regulation of collagen degradation in the rat myocardium after infarction

1 reference

12 December 2020

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction

1 reference

12 December 2020

beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure

1 reference

12 December 2020

Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow

1 reference

12 December 2020

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

12 December 2020

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function

1 reference

12 December 2020

Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)

1 reference

12 December 2020

Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

12 December 2020

Inhibition of proinflammatory cytokine production by pravastatin

1 reference

12 December 2020

Identification of patients prone to infarct expansion by the degree of regional shape distortion on an early two-dimensional echocardiogram after myocardial infarction

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors: a new mechanism of action.

1 reference

12 December 2020

Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury

1 reference

12 December 2020

Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy.

1 reference

12 December 2020

Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction

1 reference

12 December 2020

Differential effects of endothelin-1 on normal and postischemic reperfused myocardium

1 reference

12 December 2020

Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction

1 reference

12 December 2020

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

12 December 2020

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

1 reference

12 December 2020

Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage.

1 reference

12 December 2020

Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study

1 reference

12 December 2020

Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling

1 reference

12 December 2020

Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat

1 reference

12 December 2020

Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction

1 reference

12 December 2020

Benefit of beta-blockers for heart failure: proven in 1999

1 reference

12 December 2020

Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators

1 reference

12 December 2020

Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial

1 reference

12 December 2020

Effect of reperfusion on ventricular mass, topography, and function during healing of anterior infarction

1 reference

12 December 2020

Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation

1 reference

12 December 2020

Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction

1 reference

12 December 2020

Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

12 December 2020

The inflammatory response in myocardial infarction

1 reference

12 December 2020

Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning

1 reference

12 December 2020

Characterization of Endothelin-1 Receptor Subtypes in Isolated Human Cardiomyocytes

1 reference

12 December 2020

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

12 December 2020

Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning.

1 reference

12 December 2020

Aggravation of left ventricular remodeling by a novel specific endothelin ET(A) antagonist EMD94246 in rats with experimental myocardial infarction

1 reference

12 December 2020

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?

1 reference

12 December 2020

Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study

1 reference

12 December 2020

Apoptosis in ischemic and reperfused rat myocardium

1 reference

12 December 2020

Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content

1 reference

12 December 2020

Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventri

1 reference

12 December 2020

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

1 reference

12 December 2020

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

1 reference

12 December 2020

Acute myocardial infarction

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction

1 reference

12 December 2020

Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.

1 reference

12 December 2020

Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.

1 reference

12 December 2020

Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction

1 reference

12 December 2020

10.1007/S10741-008-9090-1

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18256930